Edition:
United Kingdom

Insider Trading: Spring Bank Pharmaceuticals Inc (SBPH.OQ)

SBPH.OQ on NASDAQ Stock Exchange Capital Market

6.65USD
21 May 2019
Change (% chg)

-- (--)
Prev Close
$6.65
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,949
52-wk High
$15.00
52-wk Low
$6.30

All Insider Trades
Trading Date Name Title Type Shares Traded Price
30 Apr 2019

Driscoll (Martin J)

Chief Executive Officer Buy 5,000 $7.36
30 Apr 2019

Driscoll (Martin J)

Chief Executive Officer Buy 5,000 $7.31
29 Mar 2019

Smith Scott Andrew

Director Buy 1,883 $0.00
29 Mar 2019

Arkowitz (David A.)

Director Buy 1,370 $0.00
29 Mar 2019

Clackson (Timothy P)

Director Buy 1,204 $0.00
29 Mar 2019

Brady (Todd C)

Director Buy 1,180 $0.00
2 Jan 2019

Clackson (Timothy P)

Director Buy 1,083 $0.00
2 Jan 2019

Eichler (Kurt M)

Director Buy 1,198 $0.00
1 Oct 2018

Eichler (Kurt M)

Director Buy 978 $0.00
1 Oct 2018

Bardon (Christiana)

Director and Beneficial Owner Buy 831 $0.00
1 Oct 2018

Clackson (Timothy P)

Director Buy 788 $0.00
13 Aug 2018

Driscoll (Martin J)

Chief Executive Officer Buy 4,000 $12.02
2 Jul 2018

Clackson (Timothy P)

Director Buy 744 $0.00
2 Jul 2018

Bardon (Christiana)

Director and Beneficial Owner Buy 824 $0.00
2 Jul 2018

Eichler (Kurt M)

Director Buy 957 $0.00
2 Apr 2018

Eichler (Kurt M)

Director Buy 773 $0.00
2 Apr 2018

Bardon (Christiana)

Director and Beneficial Owner Buy 641 $0.00
28 Feb 2018

Driscoll (Martin J)

Chief Executive Officer Buy 1,000 $12.83
2 Jan 2018

Eichler (Kurt M)

Director Buy 979 $0.00
2 Jan 2018

Brady (Todd C)

Director Buy 852 $0.00
2 Oct 2017

Brady (Todd C)

Director Buy 633 $0.00
2 Oct 2017

Eichler (Kurt M)

Director Buy 919 $0.00
14 Sep 2017

Driscoll (Martin J)

Chief Executive Officer Buy 1,000 $14.84
4 Aug 2017

Arkowitz (David A.)

Director Buy 200 $12.25
4 Aug 2017

Arkowitz (David A.)

Director Buy 2,300 $12.24

Institutional Holders

% Shares Owned: 43.40%
# of Holders: 81
Total Shares Held: 7,135,524
3 Mo. Net Change: 34,500
# New Positions: 3
# Closed Positions: 5
# Increased Positions: 23
# Reduced Positions: 24
# Net Buyers: -1

Officers & Directors